Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure
Authors:
- Selcuk AdabagSASelcuk Adabag
- Henri RoukozHRHenri Roukoz
- Inder S. AnandIAInder S. Anand
- Arthur J. MossAMArthur J. Moss
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation
- Boston Scientific Corporation
This publication has 30 references indexed in Scilit:
- Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart FailureNew England Journal of Medicine, 2010
- Preventing Heart Failure and Improving SurvivalNew England Journal of Medicine, 2010
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsJACC, 2009
- Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trialsEuropean Heart Journal, 2009
- Sudden Death After Myocardial InfarctionJAMA, 2008
- Comparison of the Effects of Cardiac Resynchronization Therapy in Patients With Class II Versus Class III and IV Heart Failure (from the InSync/InSync ICD Italian Registry)††Conflicts of interest: Sergio Valsecchi and Alessandra Denaro are employees of Medtronic Italia, Rome, Italy.,‡‡A list of centers and investigators participating in the InSync/InSync ICD Italian Registry is provided in the Appendix.The American Journal of Cardiology, 2007
- Cardiac Resynchronization Therapy in Patients With a Narrow QRS ComplexJACC, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart FailureCirculation, 2003
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996